e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Demystifying morphomolecular alterations of vasculature in interstitial lung diseases
Toyoshi Yanagihara, Kirk D. Jones
Source:
Eur Respir J, 55 (3) 1902446; 10.1183/13993003.02446-2019
Journal Issue:
March
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Toyoshi Yanagihara, Kirk D. Jones. Demystifying morphomolecular alterations of vasculature in interstitial lung diseases. Eur Respir J, 55 (3) 1902446; 10.1183/13993003.02446-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
The genetics of interstitial lung diseases
Source: Eur Respir Rev, 28 (153) 190053; 10.1183/16000617.0053-2019
Year: 2019
Interstitial lung diseases and systemic disorders with lung involvement
Source: ERS Skills Course 2017 - Summer school of paediatric respiratory medicine
Year: 2017
Interstitial lung diseases and systemic disorders with lung involvement
Source: ERS Skills Course 2016
Year: 2016
Morphomolecular motifs of pulmonary neoangiogenesis in interstitial lung diseases
Source: Eur Respir J, 55 (3) 1900933; 10.1183/13993003.00933-2019
Year: 2020
Cellular interactions in the pathogenesis of interstitial lung diseases
Source: Eur Respir Rev 2015; 24: 102-114
Year: 2015
The role of macrophages in interstitial lung diseases
Source: Eur Respir Rev, 26 (145) 170009; 10.1183/16000617.0009-2017
Year: 2017
Clinico-radiological profile of connective tissue diseases related interstitial lung diseases
Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause
Year: 2020
Lung ultrasound in the evaluation of interstitial lung diseases in the course of connective tissue diseases
Source: International Congress 2017 – Rare diseases
Year: 2017
Clubbing in patients with fibrotic interstitial lung diseases
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017
Prognostic factors of interstitial lung disease associated with primary Sjögren's syndrome
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
Rare interstitial lung diseases
Source: School Course 2014 - Interstitial lung diseases
Year: 2014
B cell activating factor belonging to the TNF family might be a useful biomarker in interstitial lung diseases associated with connective tissue diseases
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement
Source: Eur Respir J 2009; 33: 882-896
Year: 2009
Suppression of epithelial abnormalities by nintedanib in induced-rheumatoid arthritis-associated interstitial lung disease mouse model
Source: ERJ Open Res, 7 (4) 00345-2021; 10.1183/23120541.00345-2021
Year: 2021
Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases
Source: Eur Respir Rev, 28 (153) 190109; 10.1183/16000617.0109-2019
Year: 2019
Nitrofurantoin-induced interstitial lung disease
Source: Annual Congress 2012 - Viral infections and rare respiratory infections
Year: 2012
Antifibrotic treatment in progressive non-IPF fibrotic interstitial lung diseases
Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Year: 2019
Role of imaging in progressive-fibrosing interstitial lung diseases
Source: Eur Respir Rev, 27 (150) 180073; 10.1183/16000617.0073-2018
Year: 2018
Bleomycin induces cellular senescence in alveolar epithelial cells
Source: Eur Respir J 2003; 22: 436-443
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept